{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:36:26Z","timestamp":1765888586878,"version":"3.40.5"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Fatty Liver Index (FLI) is strongly associated with changes in glycemic status and incident Type 2 Diabetes (T2D). The probability of reverting to normoglycemia from a state prediabetes could be determined by FLI, however such relationship remains poorly understood.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Aim<\/jats:title><jats:p>To determine the clinical interest of using FLI to estimate prediabetes reversion at 5 years in patients with impaired fasting plasma glucose at baseline, and identify those factors associated with changes in FLI, that could contribute to the reversion of prediabetes.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Methods<\/jats:title><jats:p>This 5-year cohort study included 16,648 Spanish working adults with prediabetes. Prediabetes was defined as fasting plasma glucose (FPG) between 100 and 125 mg\/dl according to the ADA criteria, while prediabetes reversion was defined as a FPG &lt;100 mg\/dL. The population was classified as: FLI &lt;30 (no hepatic steatosis), FLI 30\u201359 (intermediate status), and FLI \u226560 (hepatic steatosis).<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Results<\/jats:title><jats:p>At 5 years follow-up, 33.7% of subjects reverted to normoglycemia (annual rate of 6.7%). The adjusted binomial logistic regression model showed that scoring FLI &lt;30 (OR 1.544; 95% CI 1.355\u20131.759), performing at least 150 min\/week of physical activity (OR 4.600; 95% CI 4.088\u20135.177) and consuming fruits and vegetables daily (OR 1.682; 95% CI 1.526\u20131.855) were associated with the probability of reverting form prediabetes to normoglycemia. The ROC curve for prediction of reversion showed that FLI (AUC 0.774;95% CI 0.767\u20130.781) was a better predictor than FPG (AUC 0.656; 95% CI 0.648\u20130.664).<\/jats:p><\/jats:sec><jats:sec id=\"sec005\"><jats:title>Conclusions<\/jats:title><jats:p>Regular physical activity, healthy dietary habits and absence of hepatic steatosis are independently associated with the probability of reversion to normoglycemia in adult workers with prediabetes at baseline. Low FLI values (especially FLI&lt; 30) may be useful to predict the probability of prediabetes reversion, especially in active subjects with healthy eating habits, and thus identify those who might benefit from early lifestyle intervention.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0249221","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T17:25:00Z","timestamp":1617729900000},"page":"e0249221","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Utility of Fatty Liver Index to predict reversion to normoglycemia in people with prediabetes"],"prefix":"10.1371","volume":"16","author":[{"given":"Carla","family":"Busquets-Cort\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1668-2141","authenticated-orcid":true,"given":"Miquel","family":"Bennasar-Veny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel Arturo","family":"L\u00f3pez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Fresneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aina M.","family":"Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"pone.0249221.ref001","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/ATVBAHA.117.310221","article-title":"Highlighting Diabetes Mellitus","volume":"38","author":"AM Schmidt","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"pone.0249221.ref002","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cjca.2017.12.030","article-title":"Prediabetes","volume":"34","author":"AK Khetan","year":"2018","journal-title":"Can J Cardiol"},{"key":"pone.0249221.ref003","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"P Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"pone.0249221.ref004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1464-5491.2007.02068.x","article-title":"Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: The Ely study 1990\u20132000","volume":"24","author":"NG Forouhi","year":"2007","journal-title":"Diabet Med"},{"key":"pone.0249221.ref005","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: Implications for care","volume":"30","author":"DM Nathan","year":"2007","journal-title":"Diabetes Care"},{"key":"pone.0249221.ref006","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: A high-risk state for developing diabetes","volume":"379","author":"AG Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"key":"pone.0249221.ref007","doi-asserted-by":"crossref","first-page":"i5953","DOI":"10.1136\/bmj.i5953","article-title":"Association between prediabetes and risk of cardiovascular disease and all cause mortality: Systematic review and meta-analysis","volume":"355","author":"Y Huang","year":"2016","journal-title":"BMJ"},{"key":"pone.0249221.ref008","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00125-019-4895-0","article-title":"Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study","volume":"62","author":"D Vistisen","year":"2019","journal-title":"Diabetologia"},{"key":"pone.0249221.ref009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"key":"pone.0249221.ref010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122082","article-title":"Pathophysiology of non alcoholic fatty liver disease","volume":"17","author":"S Petta","year":"2016","journal-title":"Int J Mol Sci"},{"key":"pone.0249221.ref011","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.3390\/ijerph16173104","article-title":"Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications","volume":"16","author":"C Tana","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"pone.0249221.ref012","first-page":"521","article-title":"Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus","volume":"22","author":"PGY Mala Dharmalingam","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0249221.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0221524","article-title":"Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study","volume":"14","author":"M Wargny","year":"2019","journal-title":"PLoS One"},{"key":"pone.0249221.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-015-0607-4","article-title":"Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms","volume":"15","author":"C Saponaro","year":"2015","journal-title":"Curr Diab Rep"},{"key":"pone.0249221.ref015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0124749","article-title":"Association between the fatty liver index and risk of type 2 diabetes in the EPIC-Potsdam study","volume":"10","author":"S J\u00e4ger","year":"2015","journal-title":"PLoS One"},{"key":"pone.0249221.ref016","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"S Ballestri","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"pone.0249221.ref017","article-title":"Fatty liver index and risk of diabetes incidence: A systematic review and dose-response meta-analysis of cohort studies","author":"M Movahedian","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"pone.0249221.ref018","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0028-1091983","article-title":"Diagnosis of nonalcoholic fatty liver disease: Invasive versus noninvasive","volume":"28","author":"A Wieckowska","year":"2008","journal-title":"Semin Liver Dis"},{"key":"pone.0249221.ref019","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0028-1091983","article-title":"Diagnosis of nonalcoholic fatty liver disease: Invasive versus noninvasive","volume":"28","author":"A Wieckowska","year":"2008","journal-title":"Semin Liver Dis"},{"key":"pone.0249221.ref020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.24356","article-title":"Fatty liver index and mortality: The cremona study in the 15th year of follow-up","volume":"54","author":"G Calori","year":"2011","journal-title":"Hepatology"},{"key":"pone.0249221.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-018-0858-6","article-title":"The fatty liver index (FLI) and incident hypertension: A longitudinal study among Chinese population","volume":"17","author":"K Zhou","year":"2018","journal-title":"Lipids Health Dis"},{"key":"pone.0249221.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: A simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"G Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"pone.0249221.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0198327","article-title":"Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study","volume":"13","author":"J Franch-Nadal","year":"2018","journal-title":"PLoS One"},{"key":"pone.0249221.ref024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12051538","article-title":"Lifestyle and Progression to Type 2 Diabetes in a Cohort of Workers with Prediabetes","volume":"12","author":"M Bennasar-Veny","year":"2020","journal-title":"Nutrients"},{"key":"pone.0249221.ref025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.gaceta.2012.12.009","article-title":"Propuestas de clase social neoweberiana y neomarxista a partir de la Clasificaci\u00f3n Nacional de Ocupaciones 2011","volume":"27","author":"A Domingo-Salvany","year":"2013","journal-title":"Gac Sanit"},{"key":"pone.0249221.ref026","volume-title":"ISAK","author":"A Stewart","year":"2011","edition":"3"},{"key":"pone.0249221.ref027","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","article-title":"External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study","volume":"11","author":"EM Koehler","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"pone.0249221.ref028","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1464-5491.2012.03686.x","article-title":"Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA1c and impaired fasting glucose: The Toranomon Hospital Health Management Center Study 4 (TOPICS 4)","volume":"29","author":"Y Heianza","year":"2012","journal-title":"Diabet Med"},{"key":"pone.0249221.ref029","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"M Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"pone.0249221.ref030","article-title":"Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia","volume":"2018","author":"B Richter","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0249221.ref031","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2013-1519","article-title":"Resolution of fatty liver and risk of incident diabetes","volume":"98","author":"KC Sung","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0249221.ref032","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"ME Lean","year":"2018","journal-title":"Lancet"},{"key":"pone.0249221.ref033","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cmet.2018.07.003","article-title":"Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for \u03b2 Cell Recovery","volume":"28","author":"R Taylor","year":"2018","journal-title":"Cell Metab"},{"key":"pone.0249221.ref034","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.2337\/diabetes.53.suppl_3.S26","article-title":"Beta-cell function in obesity: effects of weight loss","volume":"53","author":"E Ferrannini","year":"2004","journal-title":"Diabetes"},{"key":"pone.0249221.ref035","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"M Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"key":"pone.0249221.ref036","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s00125-011-2204-7","article-title":"Reversal of type 2 diabetes: Normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol","volume":"54","author":"EL Lim","year":"2011","journal-title":"Diabetologia"},{"key":"pone.0249221.ref037","first-page":"771","article-title":"La adiposidad como factor de riesgo del h\u00edgado graso no alcoh\u00f3lico; revisi\u00f3n sistem\u00e1tica","volume":"29","author":"A Jim\u00e9nez-Cruz","year":"2014","journal-title":"Nutr Hosp"},{"key":"pone.0249221.ref038","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/2047487317693952","article-title":"Impact of physical activity on the association of overweight and obesity with cardiovascular disease: The Rotterdam Study","volume":"24","author":"CM Koolhaas","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"pone.0249221.ref039","article-title":"The pros and cons of diagnosing diabetes with A1","volume":"34","author":"E Bonora","year":"2011","journal-title":"C. Diabetes Care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0249221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T18:48:36Z","timestamp":1698864516000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0249221"}},"subtitle":[],"editor":[{"given":"Michael W","family":"Greene","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0249221","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2021,4,6]]}}}